Abstract
Lithocholic acid and its taurine, glycine, and sulfate derivatives are potent cholestatic agents. Lithocholate glucuronide is present in the plasma and urine of patients with cholestatic syndromes, but little is known of its metabolism, excretion, and cholestatic potential. [3 beta-3H]lithocholate 3-O-beta-D-glucuronide was synthesized, and chemical and radiochemical purity were established. The aqueous solubility of lithocholate glucuronide was determined and found to be greater than that of lithocholic acid or several of its derivatives. In the range of concentrations examined, calcium ions precipitated lithocholate glucuronide stoichiometrically. The material was administered to rats prepared with an external biliary fistula. When 17-25 micrograms quantities were administered, 89.1 +/- 4.5% (mean +/- SEM) of the radiolabel was secreted in bile within the first 20 h after administration, the major fraction being secreted in less than 20 min. Four-fifths of the radiolabeled material in bile was the administered unaltered parent compound, while a minor fraction consisted of a more polar derivative(s). We showed that increasing biliary concentrations of more polar derivatives were observed with milligram doses of [3H]lithocholate glucuronide, and with time after the administration of these loading doses. Milligram doses of [3H]lithocholate glucuronide resulted in partial or complete cholestasis. When induced cholestasis was partial, secretion in bile remained the primary excretory route (82.5-105.6% recovery in bile), while, when complete cholestasis was induced, wide tissue distribution of radiolabel was observed. Cholestasis developed rapidly during infusion of [3H]lithocholate glucuronide. Bile flow was diminished within 10-20 min of the start of an infusion of 0.05 mumol, 100 g-1 body weight, minute-1, administered concomitantly with an equimolar infusion of taurocholate. The results establish that lithocholate glucuronide exerts cholestatic effects comparable to those exerted by unconjugated lithocholic acid.
MeSH Terms
Animals
Bile/analysis
Bile Acids and Salts/isolation & purification
Biliary Fistula/metabolism
Cholestasis/metabolism
Chromatography, Gas/methods
Chromatography, High Pressure Liquid/methods
Chromatography, Thin Layer/methods
Glucuronates/chemical synthesis,metabolism
Kinetics
Lithocholic Acid/chemical synthesis,metabolism
Male
Rats
Rats, Inbred Strains
Tritium
Chemicals
Bile Acids and Salts
Glucuronates
Tritium
Lithocholic Acid
lithocholate 3-O-glucuronide
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Oelberg D G
Chari M V
Little J M
Adcock E W
Lester R
References (18)
18 references, click to expand
-
The formation of lithocholic acid, chenodeoxycholic acid and alpha- and beta-muricholic acids from cholesterol incubated with rat-liver mitochondria.
Biochem J. 1967 May;103(2):472-9
PMID: 6047622
-
Constituents of human meconium--I. Identification of 3-hydroxy-etianic acids.
J Steroid Biochem. 1983 Mar;18(3):341-51
PMID: 6827839
-
Metabolism of lithocholate in healthy man. II. Enterohepatic circulation.
Gastroenterology. 1975 Jul;69(1):67-76
PMID: 1097294
-
Bile salt glucuronides: identification and quantitative analysis in the urine of patients with cholestasis.
Eur J Clin Invest. 1976 Jan 30;6(1):67-74
PMID: 1253809
-
Bile acid glucuronides, III[1, 2]. Chemical synthesis and characterization of glucuronic acid coupled mono-, di- and trihydroxy bile acids.
Hoppe Seylers Z Physiol Chem. 1976 Feb;357(2):219-24
PMID: 1254248
-
Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatorgaphy-mass spectrometry.
J Lipid Res. 1977 May;18(3):339-62
PMID: 864325
-
Relationships between calcium and cyclic nucleotides in cell activation.
Physiol Rev. 1977 Jul;57(3):421-509
PMID: 196302
-
Pathogenesis of lithocholate- and taurolithocholate-induced intrahepatic cholestasis in rats.
Gastroenterology. 1978 Oct;75(4):595-607
PMID: 213342
-
Choleretic and cholestatic effects of infused bile salts in the rat.
Experientia. 1979 Jun 15;35(6):809-11
PMID: 467601
-
The respective roles of membrane cholesterol and of sodium potassium adenosine triphosphatase in the pathogenesis of lithocholate-induced cholestasis.
Lab Invest. 1980 Jul;43(1):73-81
PMID: 6248686
-
Bile acids and their sulphated and glucuronidated derivatives in bile, plasma, and urine of children with intrahepatic cholestasis: effects of phenobarbital treatment.
Eur J Clin Invest. 1980 Aug;10(4):307-16
PMID: 6775958
-
Analysis of plasma bile acid profiles in patients with liver diseases associated with cholestasis.
Scand J Gastroenterol. 1980;15(5):593-600
PMID: 7444367
-
Lithocholate cholestasis--sulfated glycolithocholate-induced intrahepatic cholestasis in rats.
Gastroenterology. 1981 Feb;80(2):233-41
PMID: 7450414
-
Pathologic versus physiologic cholestasis: elevated serum concentration of a secondary bile acid in the presence of hepatobiliary disease.
J Pediatr. 1981 Mar;98(3):399-402
PMID: 7205448
-
Increased cholesterol and decreased fluidity of red cell membranes (spur cell anemia) in progressive intrahepatic cholestasis.
Pediatrics. 1981 Apr;67(4):461-6
PMID: 7254967
-
Sulfation of lithocholate as a possible modifier of chenodeoxycholic acid-induced elevations of serum transaminase in patients with gallstones.
J Clin Invest. 1981 Nov;68(5):1190-6
PMID: 7298846
-
Analysis of bile acid glucuronides in urine: group separation on a lipophilic anion exchanger.
Clin Chim Acta. 1982 Aug 18;123(3):275-85
PMID: 7116646
-
Effect of sodium taurolithocholate on bile flow and bile acid exeretion.
J Clin Invest. 1968 May;47(5):1002-14
PMID: 5645847